XML 102 R91.htm IDEA: XBRL DOCUMENT v3.25.3
Debt Obligations - Non-Operating Corporate CGIC Subordinated Secured Promissory Note Narrative (Details)
 3 Months Ended 9 Months Ended
Aug. 04, 2025
USD ($)
shares
Apr. 26, 2024
USD ($)
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Aug. 31, 2025
USD ($)
businessDay
Jun. 30, 2025
USD ($)
May 08, 2025
Dec. 31, 2024
USD ($)
Aug. 04, 2024
USD ($)
May 09, 2024
May 08, 2024
Jan. 31, 2024
USD ($)
Jan. 30, 2024
Dec. 31, 2023
USD ($)
Debt Instrument [Line Items]                                
Cash paid for interest         $ 27,100,000 $ 43,900,000                    
Total aggregate finance lease and debt principal payments     $ 700,400,000   700,400,000         $ 668,300,000            
Accrued interest and exit fees (current portion)     60,200,000   60,200,000         61,000,000.0            
Series A-3 and A-4 Preferred Stock                                
Debt Instrument [Line Items]                                
Dividends payable $ 500,000   500,000   500,000     $ 700,000                
CGIC | Series A-3 and A-4 Preferred Stock                                
Debt Instrument [Line Items]                                
Dividends payable     200,000   200,000                      
Non-Operating Corporate                                
Debt Instrument [Line Items]                                
Total aggregate finance lease and debt principal payments     480,100,000   480,100,000         429,900,000            
Life Sciences                                
Debt Instrument [Line Items]                                
Total aggregate finance lease and debt principal payments     46,500,000   46,500,000         24,000,000.0            
Secured Debt | Non-Operating Corporate                                
Debt Instrument [Line Items]                                
Total aggregate finance lease and debt principal payments     $ 45,100,000   $ 45,100,000                      
10.50% Senior Secured Notes | Secured Debt | Non-Operating Corporate                                
Debt Instrument [Line Items]                                
Interest rate     10.50%   10.50%   10.50%                  
Interest rate, effective percentage     14.40%   14.40%                      
Outstanding debt     $ 360,400,000   $ 360,400,000         0            
Face amount             $ 360,400,000                  
Debt covenant, mandatory prepayment, proceeds from certain asset sales, amount threshold             $ 150,000,000                  
Total aggregate finance lease and debt principal payments     342,600,000   342,600,000                      
Debt instrument, prepayment business due day | businessDay             2                  
CGIC Promissory Note | Secured Debt | Non-Operating Corporate                                
Debt Instrument [Line Items]                                
Outstanding debt     44,100,000   44,100,000         31,000,000.0            
Debt instrument, unamortized discount (premium), net     $ 1,000,000   $ 1,000,000                      
CGIC Promissory Note | Secured Debt | Non-Operating Corporate | CGIC                                
Debt Instrument [Line Items]                                
Interest rate 16.00%                              
Interest rate, effective percentage     14.60%   14.60%                      
Shares exchanged for additional principal amount | shares 8,063                              
Additional principal amount $ 9,600,000                              
Extension fee and accrued interest 2,400,000                              
Outstanding debt 43,000,000                              
Interest expense, debt     $ 1,500,000 $ 1,400,000 $ 4,200,000 4,300,000                    
Cash paid for interest     $ 0 $ 1,600,000 3,200,000 $ 3,300,000                    
Interest costs capitalized         $ 1,100,000                      
Accrued interest and exit fees (current portion)                   $ 3,400,000            
CGIC Promissory Note | Secured Debt | Non-Operating Corporate | CGIC | Series A-4 Preferred Stock                                
Debt Instrument [Line Items]                                
Additional principal amount 9,100,000                              
CGIC Promissory Note | Secured Debt | Non-Operating Corporate | CGIC | Series A-3 and A-4 Preferred Stock                                
Debt Instrument [Line Items]                                
Dividends payable 500,000                              
Unsecured Note due 2026 | Secured Debt | Non-Operating Corporate | CGIC                                
Debt Instrument [Line Items]                                
Interest rate                 32.00%     16.00% 9.00%      
Interest rate, effective percentage                   17.50%            
Face amount                               $ 35,100,000
Debt covenant, mandatory prepayment, proceeds from certain asset sales, amount threshold                               $ 3,000,000
Debt covenant, mandatory prepayment, proceeds from equity sales percentage                               12.50%
Repayments of long-term debt   $ 4,100,000                            
Gains (losses) on restructuring of debt 0                              
Senior Notes, Due 2025, 20.00% | Life Sciences | R2 Technologies | Related Party                                
Debt Instrument [Line Items]                                
Interest rate                   20.00%       20.00% 20.00%  
Face amount 20,000,000                         $ 20,000,000    
Gains (losses) on restructuring of debt $ 0                              
Accrued interest and exit fees (current portion)                     $ 7,000,000     $ 2,600,000